Panbela Therapeutics Stock (OTC: PBLA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 697.427K |
Day Range | - - - |
52 Wk Range | 0.400 - 477.000 |
Market Cap | $2.227M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Panbela Therapeutics (OTCQB: PBLA) through any online brokerage.
There are no as such competitors for Panbela Therapeutics.
The latest price target for Panbela Therapeutics (OTCQB: PBLA) was reported by HC Wainwright & Co. on Tuesday, April 2, 2024. The analyst firm set a price target for 5.00 expecting PBLA to rise to within 12 months (a possible 1036.36% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Panbela Therapeutics (OTCQB: PBLA) is $0.44 last updated April 25, 2024 at 3:12 PM EDT.
There are no upcoming dividends for Panbela Therapeutics.
Panbela Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Panbela Therapeutics.
Panbela Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.